Copyright Reports & Markets. All rights reserved.

Global Milbemycin Oxime API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Milbemycin Oxime API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Milbemycin Oxime API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 98% Purity
    • 1.3.3 Purity Greater than 98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Milbemycin Oxime API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Dog
    • 1.4.3 Cat
    • 1.4.4 Other
  • 1.5 Global Milbemycin Oxime API Market Size & Forecast
    • 1.5.1 Global Milbemycin Oxime API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Milbemycin Oxime API Sales Quantity (2018-2029)
    • 1.5.3 Global Milbemycin Oxime API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Livzon Pharmaceutical Group Inc
    • 2.1.1 Livzon Pharmaceutical Group Inc Details
    • 2.1.2 Livzon Pharmaceutical Group Inc Major Business
    • 2.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product and Services
    • 2.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Livzon Pharmaceutical Group Inc Recent Developments/Updates
  • 2.2 Zhejiang Hisun Pharmaceutical Co., Ltd
    • 2.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Details
    • 2.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Major Business
    • 2.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product and Services
    • 2.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
  • 2.3 Hubei Honch Pharmaceutical Co.,Ltd
    • 2.3.1 Hubei Honch Pharmaceutical Co.,Ltd Details
    • 2.3.2 Hubei Honch Pharmaceutical Co.,Ltd Major Business
    • 2.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product and Services
    • 2.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Developments/Updates
  • 2.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
    • 2.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Details
    • 2.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Major Business
    • 2.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product and Services
    • 2.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Developments/Updates

3 Competitive Environment: Milbemycin Oxime API by Manufacturer

  • 3.1 Global Milbemycin Oxime API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Milbemycin Oxime API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Milbemycin Oxime API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Milbemycin Oxime API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Milbemycin Oxime API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Milbemycin Oxime API Manufacturer Market Share in 2022
  • 3.5 Milbemycin Oxime API Market: Overall Company Footprint Analysis
    • 3.5.1 Milbemycin Oxime API Market: Region Footprint
    • 3.5.2 Milbemycin Oxime API Market: Company Product Type Footprint
    • 3.5.3 Milbemycin Oxime API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Milbemycin Oxime API Market Size by Region
    • 4.1.1 Global Milbemycin Oxime API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Milbemycin Oxime API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Milbemycin Oxime API Average Price by Region (2018-2029)
  • 4.2 North America Milbemycin Oxime API Consumption Value (2018-2029)
  • 4.3 Europe Milbemycin Oxime API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Milbemycin Oxime API Consumption Value (2018-2029)
  • 4.5 South America Milbemycin Oxime API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Milbemycin Oxime API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Milbemycin Oxime API Sales Quantity by Type (2018-2029)
  • 5.2 Global Milbemycin Oxime API Consumption Value by Type (2018-2029)
  • 5.3 Global Milbemycin Oxime API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Milbemycin Oxime API Sales Quantity by Application (2018-2029)
  • 6.2 Global Milbemycin Oxime API Consumption Value by Application (2018-2029)
  • 6.3 Global Milbemycin Oxime API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Milbemycin Oxime API Sales Quantity by Type (2018-2029)
  • 7.2 North America Milbemycin Oxime API Sales Quantity by Application (2018-2029)
  • 7.3 North America Milbemycin Oxime API Market Size by Country
    • 7.3.1 North America Milbemycin Oxime API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Milbemycin Oxime API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Milbemycin Oxime API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Milbemycin Oxime API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Milbemycin Oxime API Market Size by Country
    • 8.3.1 Europe Milbemycin Oxime API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Milbemycin Oxime API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Milbemycin Oxime API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Milbemycin Oxime API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Milbemycin Oxime API Market Size by Region
    • 9.3.1 Asia-Pacific Milbemycin Oxime API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Milbemycin Oxime API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Milbemycin Oxime API Sales Quantity by Type (2018-2029)
  • 10.2 South America Milbemycin Oxime API Sales Quantity by Application (2018-2029)
  • 10.3 South America Milbemycin Oxime API Market Size by Country
    • 10.3.1 South America Milbemycin Oxime API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Milbemycin Oxime API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Milbemycin Oxime API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Milbemycin Oxime API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Milbemycin Oxime API Market Size by Country
    • 11.3.1 Middle East & Africa Milbemycin Oxime API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Milbemycin Oxime API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Milbemycin Oxime API Market Drivers
  • 12.2 Milbemycin Oxime API Market Restraints
  • 12.3 Milbemycin Oxime API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Milbemycin Oxime API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Milbemycin Oxime API
  • 13.3 Milbemycin Oxime API Production Process
  • 13.4 Milbemycin Oxime API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Milbemycin Oxime API Typical Distributors
  • 14.3 Milbemycin Oxime API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Milbemycin Oxime API market size was valued at USD 189 million in 2022 and is forecast to a readjusted size of USD 286.7 million by 2029 with a CAGR of 6.1% during review period.
    Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.
    Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.
    The Global Info Research report includes an overview of the development of the Milbemycin Oxime API industry chain, the market status of Dog (98% Purity, Purity Greater than 98%), Cat (98% Purity, Purity Greater than 98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Milbemycin Oxime API.
    Regionally, the report analyzes the Milbemycin Oxime API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Milbemycin Oxime API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Milbemycin Oxime API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Milbemycin Oxime API industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (KG), revenue generated, and market share of different by Type (e.g., 98% Purity, Purity Greater than 98%).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Milbemycin Oxime API market.
    Regional Analysis: The report involves examining the Milbemycin Oxime API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Milbemycin Oxime API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Milbemycin Oxime API:
    Company Analysis: Report covers individual Milbemycin Oxime API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Milbemycin Oxime API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Dog, Cat).
    Technology Analysis: Report covers specific technologies relevant to Milbemycin Oxime API. It assesses the current state, advancements, and potential future developments in Milbemycin Oxime API areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Milbemycin Oxime API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Milbemycin Oxime API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    98% Purity
    Purity Greater than 98%
    Market segment by Application
    Dog
    Cat
    Other
    Major players covered
    Livzon Pharmaceutical Group Inc
    Zhejiang Hisun Pharmaceutical Co., Ltd
    Hubei Honch Pharmaceutical Co.,Ltd
    JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Milbemycin Oxime API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Milbemycin Oxime API, with price, sales, revenue and global market share of Milbemycin Oxime API from 2018 to 2023.
    Chapter 3, the Milbemycin Oxime API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Milbemycin Oxime API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Milbemycin Oxime API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Milbemycin Oxime API.
    Chapter 14 and 15, to describe Milbemycin Oxime API sales channel, distributors, customers, research findings and conclusion.

    Buy now